Subscribe To
Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resis...
October 14, 2023, 4:30 pm
It was a story about stock markets that popularized the unluckiness of friday the 13th
Today we associate Friday the 13th with horror movies and unluckiness but its history goes back much further. In Europe, 13 was long considered an unl...
October 13, 2023, 1:47 pm
Pharvaris to present at the apaaaci 2023 international conference
ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...
October 13, 2023, 6:50 am
Virios therapeutics to present at the thinkequity conference on thursday, october 19, 2023
ATLANTA, Oct. 12, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company fo...
October 12, 2023, 11:05 am
Miromatrix to present at the 2023 isodp organ donation congress
EDEN PRAIRIE, Minn., Oct. 11, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a ...
October 11, 2023, 8:05 pm
Palisade bio to participate at the virtual investor ask the ceo conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October 25th at 2:00 PM ET Carlsbad, CA, Oct. 11, 2023 ...
October 11, 2023, 1:05 pm
Arbutus announces multiple abstracts accepted for presentation at aasld – the liver meeting® 2023
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Na...
October 11, 2023, 12:05 pm
Is recursion pharmaceuticals stock a buy now?
Recursion Pharmaceuticals is using a novel and promising approach to drug discovery. Its strategy has p...
October 11, 2023, 10:07 am
Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
Sellas receives fda orphan drug designation for sls009 for treatment of acute myeloid leukemia
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clini...
October 10, 2023, 8:15 pm
The bitcoin 16 year cycle, and it’s correlation to the internet bubble
Jeroen van Lange introduces his novel theory on Bitcoin market cycles, and what most people could be ge...
October 10, 2023, 2:14 pm
Cybrexa therapeutics to debut preclinical data demonstrating cbx-15 is safe and highly efficacious in 13762 triple negative breast cancer model at 35th aacr-nci-eortc symposium
Preclinical Data Demonstrate CBX-15’s Anti-Tumor Efficacy in Animal Models and Ability to Enhance Immunogenicity and Induce Immune Memory through pH...
October 10, 2023, 12:05 pm
Cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the...
October 10, 2023, 8:15 am
Harpoon therapeutics to present interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company deve...
October 9, 2023, 4:17 pm
Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...
October 9, 2023, 4:10 pm
Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...
October 9, 2023, 12:10 pm
A look back at canada's september etf launches
September was a quiet month for ETF launches following a busy summer of launches for Canada's ETF industry. A total of seven new ETFs launched last mo...
October 9, 2023, 11:45 am
Algae supplements market is expected to reach a valuation of us$ 2.07 billion by 2033 : fact.mr report
The increasing research and development efforts focused on discovering novel algae species with unique ...
October 8, 2023, 9:00 pm
3 space stocks to jettison before they crash
The space market has already grown to $447 billion since the start of 2023 and could grow to $1 trillion by 2030, according to figures compiled by the...
October 8, 2023, 9:00 am
Opko health (opk) gets barda contract to combat antibody threats
OPKO Health's (OPK) latest awarded funding is likely to enable the development of novel multispecific a...
October 6, 2023, 1:32 pm